Scientists probe immune System's role in chronic disease
NCT ID NCT01143480
First seen Jun 27, 2026 · Last updated Aug 07, 2026 · Updated 6 times
Summary
This study looks at how the body's innate immune system responds to certain environmental exposures by measuring inflammation markers in blood. Researchers will collect blood samples from up to 725 healthy volunteers aged 18-45 to analyze how specific genes and proteins react. The goal is to better understand how these responses might contribute to chronic illnesses like asthma, atherosclerosis, and cancer.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help explain how environmental factors trigger inflammation that may lead to chronic diseases.
- What could go wrong
- This is an observational study in healthy volunteers, not a treatment trial. It may not directly lead to new therapies or apply to people with existing conditions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
NIEHS Clinical Research Unit (CRU)
RECRUITINGResearch Triangle Park, North Carolina, 27709, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A good Night's sleep: could a simple program ease Cancer's toll on rest?
- Can tracking severe asthma over time unlock better treatments?
- Could sitting up make radiation therapy more comfortable?
- Can we predict dangerous side effects when combining radiation and immunotherapy?
- Family history as a shield: can culturally tailored guidance cut cancer risk?
- Seaweed extract may tackle fatty liver Disease—A trial puts it to the test